Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Form 8.3 -INSTEM PLC

3 Oct 2023 14:25

RNS Number : 5625O
Barclays PLC
03 October 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

INSTEM PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

02 Oct 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

10p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

325,000

1.42%

0

0.00%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

0

0.00%

325,000

1.42%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

325,000

1.42%

325,000

1.42%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

10p ordinary

Purchase

32,393

8.2057Ă‚ GBP

10p ordinary

Purchase

17,607

8.2549Ă‚ GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

10p ordinary

SWAP

Short

17,607

8.2549Ă‚ GBP

10p ordinary

SWAP

Short

32,393

8.2057Ă‚ GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i)Ă‚ the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

03 Oct 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKNBBNBDDQKK
Date   Source Headline
1st Sep 20217:00 amRNSAcquisition of PDS Pathology Data Systems
19th Jul 20217:00 amRNSHalf Year Trading Update
16th Jun 20213:30 pmRNSHolding(s) in Company
14th Jun 20217:00 amRNSNotice of Capital Markets Day
27th May 20213:48 pmRNSResult of AGM
20th May 20214:56 pmRNSHolding(s) in Company
11th May 202111:52 amRNSHolding(s) in Company
5th May 20217:32 amRNSHolding(s) in Company
20th Apr 20214:45 pmRNSExercise of Options, Issue of Equity and TVR
19th Apr 202112:10 pmRNSGrant of Options
19th Apr 20217:00 amRNSHolding(s) in Company
15th Apr 20215:45 pmRNSHolding(s) in Company
12th Apr 20217:00 amRNSFinal Results
1st Apr 20214:30 pmRNSCompletion of Acquisition of d-wise
30th Mar 20217:00 amRNSNotice of Results
22nd Mar 20217:00 amRNSAcquisition of d-wise and Investor Presentation
1st Mar 20217:00 amRNSAcquisition of The Edge
14th Jan 20217:00 amRNSTrading Update
15th Dec 20207:00 amRNSNew Business Update
27th Oct 20207:00 amRNSInvestor Presentation
28th Sep 20207:00 amRNSHalf-year Report
15th Sep 20207:00 amRNSNotice of Results
9th Sep 202012:14 pmRNSHolding(s) in Company
13th Aug 202012:40 pmRNSHolding(s) in Company
22nd Jul 202010:27 amRNSHolding(s) in Company
21st Jul 202011:53 amRNSHolding(s) in Company
20th Jul 20205:37 pmRNSHolding(s) in Company
20th Jul 20205:36 pmRNSHolding(s) in Company
20th Jul 202011:52 amRNSHolding(s) in Company
20th Jul 20207:00 amRNSHalf Year Trading Update
17th Jul 20203:42 pmRNSHolding(s) in Company
17th Jul 202012:38 pmRNSHolding(s) in Company
17th Jul 202012:34 pmRNSHolding(s) in Company
17th Jul 20209:15 amRNSDirector/PDMR Dealings
16th Jul 202012:27 pmRNSResult of General Meeting, Issue of Equity and TVR
8th Jul 20207:00 amRNSInvestor Communications
3rd Jul 20203:54 pmRNSHolding(s) in Company
30th Jun 20205:33 pmRNSPublication of Circular and Notice of GM
30th Jun 20202:56 pmRNSResult of AGM
26th Jun 20202:00 pmRNSResult of Placing
26th Jun 20207:00 amRNSProposed Placing
3rd Jun 20207:01 amRNSContract Win
3rd Jun 20207:00 amRNSFinal Results
29th May 20207:00 amRNSNotice of Results
25th Mar 20207:00 amRNSUpdate to Results Announcement Date
24th Feb 20207:00 amRNSNotice of Results
13th Feb 202010:40 amRNSExercise of Options/Issue of Equity
13th Jan 20207:00 amRNSTrading Update
16th Dec 20195:48 pmRNSExercise of Options and Total Voting Right
18th Nov 201910:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.